The objective of this work was to determine whether normothermic global cardiac ischemia in a porcine model was associated with a change in the density (B,,,) of voltage-dependent calcium channels in myocardial sarcolemmal membranes. Pigs were anesthetized, a thoracotomy was performed, and samples were taken of the left and right ventricles from control and ischemic hearts. Dihydropyridine-binding sites were quantified using [3H]isradipine, and 5'-nucleotidase activity was measured by the liberation of inorganic phosphate from adenosine monophosphate. B,,, and dissociation constants and 5'-nucleotidase activity for control and ischemic tissues, respectively, were compared by using Student's t-test for unpaired samples.
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After normothermic global ischemia, the B,,, of 13H]isradipine binding increased in the left ventricle by 81% (299% -C 1.7% to 540% ? 11% fmoles/mg, P < 0.01) and in the right ventricle by 33% (387% ? 9.9% to 515% + 38% fmoles/mg, P < 0.01) compared with control. 5'-nucleotidase activity increased by 48% in the left ventricle and by 96% in the right ventricle (p < 0.05). Fifteen minutes of normothermic ischemia in the pig is associated with marked sarcolemmal abnormalities, including increases in specific dihydropyridine binding and 5'-nucleotidase activity, which reflect global changes in membrane function, which might contribute to the increase in myoplasmic calcium during ischemia.
( In the present study, we induced normothermic global cardiac ischemia in a porcine model and measured the specific binding of [3H] isradipine to cardiac sarcolemmal membranes and the activity of the sarcolemmal marker enzyme, 5'-nucleotidase.
We previously demonstrated, in a canine ventricular fibrillation model of cerebral ischemia, a 300% increase in the specific binding of 13H]isradipine to cerebral cortical membranes derived from ischemic cerebral cortex (7). Although the isoform of the L-type VDCC is different in the heart than that in the brain, we hypothesized that a similar increase in dihydropyridine receptor density might occur in the heart and contribute to the increased myoplasmic calcium that occurs in ischemic myocardium.
Methods
After approval by the animal care and use committees, pigs were premeditated with 20 mg/ kg ketamine and anesthetized with 30 mg / kg pentobarbital, intubated, and ventilated. The investigation conforms with the Guide fey the Care and Use of Laboratory Animals published by the National Institutes of Health (1996) animal was treated with 2 mg/kg bretylium tosylate to prevent arrhythmias prior to the performance of midline sternotomy. Control hearts were completely excised from the chest and placed immediately in ice-cold buffer. The experimental animals underwent 15 min of normothermic global ischemia, which was induced by cross-clamping the aorta and venting the vena cavae to prevent distension. After 15 min of ischemia, the hearts were excised and placed in icecold buffer. Samples of the right and left ventricles were taken from control and ischemic hearts. Membranes were prepared immediately, or the tissue was frozen in liquid nitrogen and the membranes prepared within 2 days.
Cardiac sarcolemmal membranes were prepared from specimens of the right and left ventricles by the method of Endoh et al. (8) . Briefly, the ventricular tissue was minced in 0.25 M sucrose, 5 mM Tris/HCl, 1 mM MgCl,, pH 7.2, and homogenized with a Polytron@ (Brinkman Instruments, Littau, Swizterland) three times for 15 s each. The homogenate was centrifuged at 5008 for 15 min at 4°C. The supernatant was filtered through a single layer of cheesecloth and centrifuged at 50,OOOg for 20 min at 4°C. The pellet was washed twice in 50 mM Tris / HCl, 10 mM MgCl, at pH 7.5. The pellet was resuspended in the same medium at a concentration of l-2 mg / mL. The protein concentration was determined by the method of Bradford (9).
[3H]Isradipine Binding Assay One hundred micrograms of sarcolemmal membranes were incubated at 25°C for 60 min in 50 mM Tris/HCl with [3H]isradipine at the following concentrations: 0.05, 0.105, 0.26, 0.53, and 1.05 nM (10). To define nonspecific binding, samples were incubated with the radioligand along with 500 nM unlabelled nitrendipine. The reaction was stopped by the addition of 10 mL of cold buffer, and then the samples were filtered with a cell harvester (Brandel Biomedical Research Development Laboratories, Gaithersburg, MD). Each concentration was examined in triplicate with and without nitrendipine.
Specific binding, which is plotted in Figure 1 , is defined as the difference between total binding and nonspecific binding.
The mean of specific binding at each concentration was plotted, and the data were fit by nonlinear regression analysis to a one-site binding equation using the Enzfitter (Biosoft, Cambridge, UK) program.
5'-Nucleotidase Activity Assay
Seventy-five to two hundred micrograms of sarcolemma1 membrane was incubated in 50 mM Tris/HCl buffer with 5 mM MgCl, and 1 mM adenosine monophosphate for 15 min at 37°C for 30 min. The reaction, which had a total volume of 100 pL, was stopped by the addition of 900 PL 10% trichloroacetate and centrifuged at 15,000 rpm for 10 min. One hundred microliters of supernatant was then analyzed for inorganic phosphate by using the malachite green microassay (11). A standard curve was generated with KH,PO, and samples were compared with the standard curve.
Statistical Analysis
Binding data from control and ischemic tissue were compared by two-way analysis of variance. The binding data were also fit by nonlinear regression analysis to a one-site binding equation using the computer program Enzfitter. The derived B,,, and dissociation constant values for control and ischemic membranes were compared by using the unpaired Student's t-test. 5'-nucleotidase activities of control and ischemic sarcolemmal membranes were also compared by using the unpaired Student's t-test. to sarcolemmal membranes and indicates an increase in the density of calcium-channel antagonist binding sites in ischemic tissue. There was an 81% increase in B max for isradipine binding in sarcolemmal membranes derived from ischemic left ventricular tissue (n = 7), which is statistically significantly different from control (n = 12) at the P < 0.01 level. Two-way analysis of variance of the binding data demonstrated a statistically significant difference between control and ischemic membranes, P < 0.05. Sarcolemmal membranes from the right ventricle demonstrated the same trend, but the increase was only 33%. We also observed a slight increase in the dissociation constant for isradipine, as indicated by the Scatchard plot (Figure 1 insert) , but this was not statistically significant. The summary data for left and right ventricles are given in Table 1. S'-Nucleotidase Activity 5'-nucleotidase activity was measured in sarcolemmal membranes from control and ischemic hearts as a marker for sarcolemma. As shown in Figure 2 , there was a statistically significant increase (P < 0.01) in activity in membranes derived from both ventricles. The 5'-nucleotidase activity increased by 48% and 96%, respectively, in both right and left ventricles (Table 1) .
Discussion
Fifteen minutes of normothermic ischemia leads to intracellular hypoxia, acidosis, the depletion of intracellular adenosine triphosphate, and loss of ion gradients (12). This period of ischemia in the porcine model resulted in a "stunned" myocardium, i.e., reversible contractile dysfunction without structural abnormalities of the myocardium.
In the present study, we examined two biochemical activities associated with the sarcolemmal membrane, [3H]isradipine binding to VDCC and the activity of 5'-nucleotidase.
Both have been implicated in the processes of ischemia and reperfusion injury (5,13). An increase in intracellular calcium has been observed in other models of global ischemia, and the inhibition of this increase and improvement in contractile function after pretreatment with a calcium-channel antagonist implicates the L-type VDCC in the pathophysiology of stunning. The enzyme 5'-nucleotidase enhances the catabolism of nucleotides by dephosphorylating adenosine monophosphate, which results in the production of adenosine. We demonstrate herein that 15 minutes of ischemia without reperfusion is associated with marked augmentation in both sarcolemmal functions. The density of VDCC in the sarcolemmal membrane can be determined with the radiolabelled dihydropyridine, [3H]isradipine (4). It was assumed that the increase in B,,, was associated with an increase in functional VDCC in the ischemic heart. This is obviously a point that requires further investigation, but the evidence that calcium-channel antagonists can prevent the rise in intracellular calcium associated with brief periods of ischemia supports this contention (1,6). Our observation of increased B,,, is markedly different from the findings of others, who observed either no change during brief ischemia or decreases in phenylalkylamine and dihydropyridine binding to membranes derived from tissue exposed to prolonged ischemia (14 -16). Those experiments utilized ischemic times of lo-60 minutes and examined binding sites in rat heart membranes rather than in pig hearts, which is one potential explanation for the distinct difference from our results. However, using a canine model of regional cardiac ischemia, Drenger et al. (17) demonstrated an increase in B,,, of VDCC in membranes derived from the ischemic region.
5'-nucleotidase activity was measured as a marker for the sarcolemma. We did not expect to find an increase in its activity with ischemia, since Nayler et al. (14) had reported a small decrease in 5'-nucleotidase activity in severely ischemic tissue. Our original intention was to normalize VDCC density to the 5'-nucleotidase activity to assess whether the density of the VDCC was specifically altered within a constant sarcolemmal environment. As shown in Figure 2 , the increase in 5'-nucleotidase activity was comparable to the change in VDCC density, which suggests global, and not subtle, changes in sarcolemmal integrity in the brief 15-minute period of ischemia. The finding of increased 5'-nucleotidase activity actually fits the observation of increased production of adenosine during ischemia. It also has been suggested that enhanced 5'-nucleotidase activity exacerbates the inability to synthesize adenosine triphosphate upon reperfusion because of the depletion of adenosine monophosphate and the production of diffusible adenosine that can leave the cell. Furthermore, adenosine has been linked to the adenosine triphosphatedependent K+ channel and is believed to be a mediator of ischemic preconditioning.
The increased 5'-nucleotidase activity alternatively suggests that we might be isolating membranes with a higher specific activity, i.e., greater purity, from the ischemic hearts comparison with the control hearts, despite the fact that the yield of sarcolemmal membranes was the same in both. Recently, Zucchi et al. (18) examined the subcellular distribution of [3H]isradipine binding sites as well as quinuclidinyl benzilate, a muscarinic receptor antagonist, and ouabain binding as markers of the sarcolemma in rat hearts after 20 minutes of global ischemia. They found no substantial change from control in the distribution or the quantity of binding sites. It is unclear whether the increased activity of 5'-nucleotidase and increased B max for [3H]isradipine binding that we observed might result from sarcolemmal precursor membranes localizing to the sarcolemma during ischemia.
Our results demonstrate that a brief period of ischemia is associated with marked alterations in activities normally associated with the sarcolemma. These changes were observed with ischemia alone without reperfusion. The reversibility of these augmented activities has not yet been determined, but our previous examination of increased VDCC density in cerebral cortical membranes from ischemic canines showed a return toward control values after 24 hours of reperfusion (7). More importantly, these results suggest a possible mechanism for the increase of intracellular calcium during myocardial ischemia and early reperfusion and for the increased production of adenosine in ischemic tissue. Our future investigations will be aimed at determining whether the increase in VDCC density is associated with an increase in the number of functional VDCC in the ischemic heart and the effect of reperfusion on VDCC density and function. While stunning is a reversible process, it is unclear at this time what, if any, role VDCC play in the mechanism of myocardial stunning and the reversal of stunning. 
